@prefix bibo: <http://purl.org/ontology/bibo/> .
@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-HBM4EU-HB001962 a mbo:MassSpectrum ;
    dcterms:creator "Annelaure Damont, Kathleen Rousseau, Laboratoire d Etude du Metabolisme des Medicaments, CEA, Universite Paris Saclay, Paris, France" ;
    dcterms:date "2020-02-20"^^xsd:date ;
    dcterms:identifier "MSBNK-HBM4EU-HB001962" ;
    dcterms:license <https://creativecommons.org/licenses/by-sa/4.0/> ;
    dcterms:references [ a bibo:Article ;
            rdfs:label "Oberacher H, Sasse M, Antignac J-P, Guitton Y, Debrauwer L, Jamin E L, Schulze T, Krauss M, Covaci A, Caballero-Casero N, Rosseau K, Damont A, Fenaille F, Lamoree M, Schymanski E, A European proposal for quality control and quality assurance of tandem mass spectral libraries, Environmental Sciences Europe, https://doi.org/10.1186/s12302-020-00314-9" ] ;
    dcterms:rights "Copyright (c) 2020 by Laboratoire d Etude du Metabolisme des Medicaments, CEA, Universite Paris Saclay, Paris, France under CC0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Orbitrap Fusion Tribrid Thermo Fisher Scientific" ;
            mbo:collision_energy "20% (nominal)" ;
            mbo:flow_gradient "95/5" ;
            mbo:flow_rate "100 uL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-QFT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "30000" ;
            mbo:solvent "A water with 0.1% formic acid",
                "B acetonitrile with 0.1% formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide",
                "Amiloride" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 2.290479e+02 ;
            rdfs:seeAlso cas:2609-46-3,
                pubchem:CID16231 ;
            schema:inChI "InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)" ;
            schema:inChIKey inchikey:XSDQTOBWRPYKKA-UHFFFAOYSA-N ;
            schema:molecularFormula "C6H8ClN7O" ;
            schema:name "3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide",
                "Amiloride" ;
            schema:smiles "NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N" ] ;
    mbo:has_peak [ mbo:intensity 2.070647e+07 ;
            mbo:mz 6.00558e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 591 ],
        [ mbo:intensity 3.440922e+07 ;
            mbo:mz 1.710069e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 982 ],
        [ mbo:intensity 1.459301e+06 ;
            mbo:mz 1.880335e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 42 ],
        [ mbo:intensity 7.676845e+06 ;
            mbo:mz 1.890175e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 219 ],
        [ mbo:intensity 1.867204e+06 ;
            mbo:mz 2.130287e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 53 ],
        [ mbo:intensity 3.50221e+07 ;
            mbo:mz 2.300552e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 3.188062e+05 ;
            mbo:mz 6.10398e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 9 ],
        [ mbo:intensity 1.940925e+06 ;
            mbo:mz 8.60351e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 55 ],
        [ mbo:intensity 2.90333e+04 ;
            mbo:mz 1.009906e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 1 ],
        [ mbo:intensity 1.913258e+05 ;
            mbo:mz 1.160012e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 5 ],
        [ mbo:intensity 1.063621e+05 ;
            mbo:mz 1.43012e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 2.085216e+05 ;
            mbo:mz 1.450276e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 4.628871e+05 ;
            mbo:mz 1.610226e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 13 ],
        [ mbo:intensity 1.334342e+05 ;
            mbo:mz 1.700228e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 4 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz_value "230.0552"^^xsd:float ;
            mbo:precursor_type_value "[M+H]+" ] ;
    mbo:pk_num_peak 14 ;
    mbo:pk_splash "splash10-01x0-4970000000-f45a59769974d7af3d5d" ;
    rdfs:comment "Flow Injection" ;
    skos:definition "Amiloride; LC-ESI-QFT; MS2; CE: 20%; R=30000; [M+H]+" .

